Substantial biomanufacturing facility on a Premier Science and Innovation Park
Approx. GIA 15,944.00 sq. m. (171,619 sq. ft.) on a Site of 5.00 Acres (2.02 Ha)
Includes service yard and car park for approximately 88 cars
Located on the prestigious Harwell Science and Innovation Campus in Oxford, one of Oxford's most admired business, life science and technology innovation hubs
Nearby occupiers include Moderna, Faraday Institution, European Space Agency, UK Health Security Agency and Rosalind Franklin Institute
Substantial biomanufacturing facility on a Premier Science and Innovation Park
Approx. GIA 15,944.00 sq. m. (171,619 sq. ft.) on a Site of 5.00 Acres (2.02 Ha)
Includes service yard and car park for approximately 88 cars
Located on the prestigious Harwell Science and Innovation Campus in Oxford, one of Oxford's most admired business, life science and technology innovation hubs
Nearby occupiers include Moderna, Faraday Institution, European Space Agency, UK Health Security Agency and Rosalind Franklin Institute
Lot 9
Auction 6th May 2026
Vacant Possession
Status Available
Guide* £3,500,000
Sector Biomanufacturing/Industrial
Auction Venue Live Streamed Auction
Property Information
Location
Miles
16 miles south of Oxford City Centre, 26 miles north-west of Reading, 66 miles west of London
Roads
A34, A4185, M4,
Rail
Didcot Parkway Railway Station
Air
Heathrow Airport
Situation
The property is prominently situated on Thomson Avenue, within the Harwell Science and Innovation Campus (HSIC), one of the UK's leading life science, technology and business parks. The property benefits from excellent road communications via the nearby A34, providing direct access to the M4 (Junction 13) to the south and the M40 (Junction 9) to the north. Neighbouring occupiers on Harwell Campus include Moderna, Faraday Institution, European Space Agency, UK Health Security Agency and Rosalind Franklin Institute. Within Oxford, HSIC is one of the key science parks across the innovation cluster. Across the wider cluster there is close to 2.8m sq. ft. of commercial lab space between 15 science park locations, home to over 450 Life Sciences companies.
Tenure
Long Leasehold. Held on a lease for 100 years from 03/12/2020 until 02/12/2120 at a current rent of £478,653 per annum. The rent is annually reviewed and indexed to RPI, upward only. The lease includes the Use as Scientific and technological purposes (excluding call centres or general industrial manufacturing except for biopharma).
Location
Miles
16 miles south of Oxford City Centre, 26 miles north-west of Reading, 66 miles west of London
Roads
A34, A4185, M4,
Rail
Didcot Parkway Railway Station
Air
Heathrow Airport
Situation
The property is prominently situated on Thomson Avenue, within the Harwell Science and Innovation Campus (HSIC), one of the UK's leading life science, technology and business parks. The property benefits from excellent road communications via the nearby A34, providing direct access to the M4 (Junction 13) to the south and the M40 (Junction 9) to the north. Neighbouring occupiers on Harwell Campus include Moderna, Faraday Institution, European Space Agency, UK Health Security Agency and Rosalind Franklin Institute. Within Oxford, HSIC is one of the key science parks across the innovation cluster. Across the wider cluster there is close to 2.8m sq. ft. of commercial lab space between 15 science park locations, home to over 450 Life Sciences companies.
Tenure
Long Leasehold. Held on a lease for 100 years from 03/12/2020 until 02/12/2120 at a current rent of £478,653 per annum. The rent is annually reviewed and indexed to RPI, upward only. The lease includes the Use as Scientific and technological purposes (excluding call centres or general industrial manufacturing except for biopharma).
Description
The property comprises a substantial two storey former biomanufacturing facility arranged over ground, mezzanine and first floors.
The property also benefits from access via the rear through the service yard, a car park for approximately 88 cars and an internal eaves height of 12m (39 ft) to the production area. The property is also fully fitted out with the benefit of a full roster of specialist equipment.
Originally developed as the Vaccine Manufacturing Innovation Centre (VMIC) reportedly costing £205m to deliver, this 171,619 sq. ft. GIA facility has since been repurposed by the current owner while retaining its original design to mass produce vaccine treatments.
The property comprises a substantial two storey former biomanufacturing facility arranged over ground, mezzanine and first floors.
The property also benefits from access via the rear through the service yard, a car park for approximately 88 cars and an internal eaves height of 12m (39 ft) to the production area. The property is also fully fitted out with the benefit of a full roster of specialist equipment.
Originally developed as the Vaccine Manufacturing Innovation Centre (VMIC) reportedly costing £205m to deliver, this 171,619 sq. ft. GIA facility has since been repurposed by the current owner while retaining its original design to mass produce vaccine treatments.
If you are the successful bidder, Acuitus requires a separate payment of £1,500+VAT as a buyer's administration charge payable to Acuitus Limited upon exchange of contracts. A VAT receipt will be provided upon payment.
